Department of Neurosurgery, Faculty of Medical Sciences, Fukui, Japan.
Eur J Nucl Med Mol Imaging. 2011 Jun;38(6):1075-82. doi: 10.1007/s00259-011-1734-z. Epub 2011 Feb 2.
[(62)Cu]Diacetyl-bis(N (4)-methylthiosemicarbazone) ((62)Cu-ATSM) was used to evaluate brain haemodynamic impairment in patients with cerebrovascular disease (CVD) as a simplified evaluation method. The tracer distribution was compared with haemodynamic parameters obtained by (15)O positron emission tomography (PET).
Ten patients with major cerebral arterial occlusive disease (aged 66 ± 7 years) underwent PET with (62)Cu-ATSM and (15)O tracers ((15)O-water, (15)O(2) and C(15)O). Seven healthy volunteers also underwent (62)Cu-ATSM PET as normal controls. After the injection of (62)Cu-ATSM, 20-min dynamic PET data acquisition was started. Early- and delayed-phase images of (62)Cu-ATSM were obtained by averaging the initial 3-min and the last 10-min frame data, which were used for perfusion and retention images. Cerebral blood flow (CBF), blood volume, metabolic rate of oxygen (CMRO(2)) and oxygen extraction fraction (OEF) were measured by (15)O-gas and water studies and compared with early- and delayed-phase (62)Cu-ATSM images and delayed to early (D/E) ratio. Regional values were compared after all parametric images were coregistered to individual MRI. The asymmetry index (AI) was also calculated for OEF and Cu-ATSM D/E ratio, and diagnostic ability for detecting misery perfusion was compared.
In the affected hemisphere of the patients, the mean values of haemodynamic parameters were CBF = 33.8 ± 5.9 ml/100 g per min, CMRO(2) = 2.6 ± 0.3 ml/100 g per min and OEF = 48 ± 7%. Standardized uptake values (SUVs) for (62)Cu-ATSM in early and delayed phases were 2.00 ± 0.13 and 1.04 ± 0.09 in the ipsilateral hemisphere and 2.13 ± 0.14 and 1.04 ± 0.08 in the contralateral hemisphere, respectively. The early-phase (62)Cu-ATSM images corresponded well to CBF images, and the D/E ratio images were similar to OEF images. Regional values obtained from D/E ratio images were significantly correlated with regional OEF. AIs of OEF and D/E ratio showed a significant correlation and diagnostic ability of misery perfusion was slightly better in AI of D/E ratio than that of OEF.
Dynamic PET acquisition with (62)Cu-ATSM provided information on CBF distribution and local elevation of OEF in patients with chronic CVD. The findings of the present study showed the feasibility of the noninvasive molecular imaging method for diagnosing misery perfusion with a single venous tracer injection.
[(62)Cu]二乙酰基-双(N(4)-甲基硫代半卡巴腙)([(62)Cu-ATSM)被用于评估脑血管疾病(CVD)患者的脑血液动力学损伤,作为一种简化的评估方法。将示踪剂分布与通过(15)O 正电子发射断层扫描(PET)获得的血液动力学参数进行比较。
10 名患有主要大脑动脉闭塞性疾病的患者(年龄 66±7 岁)接受了(62)Cu-ATSM 和(15)O 示踪剂((15)O-水、(15)O2 和 C(15)O)的 PET。7 名健康志愿者也作为正常对照接受了(62)Cu-ATSM PET。在注射(62)Cu-ATSM 后,开始进行 20 分钟的动态 PET 数据采集。通过平均初始 3 分钟和最后 10 分钟帧数据获得(62)Cu-ATSM 的早期和延迟相图像,用于灌注和保留图像。通过(15)O-气体和水研究测量脑血流量(CBF)、血容量、氧代谢率(CMRO2)和氧提取分数(OEF),并与早期和延迟相(62)Cu-ATSM 图像和延迟到早期(D/E)比进行比较。在将所有参数图像配准到个体 MRI 后,比较区域值。还为 OEF 和 Cu-ATSM D/E 比计算了不对称指数(AI),并比较了检测痛苦灌注的诊断能力。
在患者的受影响侧半球,血液动力学参数的平均值为 CBF=33.8±5.9ml/100g/min,CMRO2=2.6±0.3ml/100g/min,OEF=48±7%。同侧半球早期和延迟相(62)Cu-ATSM 的标准化摄取值(SUV)分别为 2.00±0.13 和 1.04±0.09,对侧半球分别为 2.13±0.14 和 1.04±0.08。早期相(62)Cu-ATSM 图像与 CBF 图像吻合良好,D/E 比图像与 OEF 图像相似。D/E 比图像获得的区域值与区域 OEF 显著相关。OEF 和 D/E 比的 AI 呈显著相关性,D/E 比的 AI 诊断痛苦灌注的能力略优于 OEF 的 AI。
(62)Cu-ATSM 的动态 PET 采集提供了慢性 CVD 患者 CBF 分布和局部 OEF 升高的信息。本研究的结果表明,使用单一静脉示踪剂进行非侵入性分子成像方法诊断痛苦灌注是可行的。